Skip to content

Rhizarthrosis Surgery and Functional Recovery: Arthroplasty vs. Trapezectomy

Comparing Short-Term Functional Recovery After Surgery for Rhizarthrosis: Arthroplasty vs. Trapezectomy - A Prospective Randomized Evaluation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06078189
Acronym
TRAPEzE
Enrollment
50
Registered
2023-10-11
Start date
2023-11-24
Completion date
2028-12-01
Last updated
2026-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhizarthrosis

Keywords

osteoarthritis - Trapezectomy

Brief summary

Rhizarthrosis is a form of osteoarthritis that affects the trapeziometacarpal joint at the base of the thumb, which is more common in women over 50. Genetic and hormonal factors as well as the frequency of certain physical movements may contribute to its appearance. Surgical treatment is recommended if medical treatment fails, and trapezectomy is currently considered the standard method, although 3rd generation trapeziometacarpal prostheses are also available. The aim of this study is to compare the clinical and radiographic results after surgical treatment of rhizarthrosis: prosthesis versus trapezectomy.

Detailed description

This is a two-center, randomized, prospective, comparative study. The functional, clinical and radiographic evaluation in the early, medium and long term will make it possible to determine the possible superiority of arthroplasty if it exists. The close evaluation of the patients during the first 3 months will make it possible to update the superiority of the arthroplasty on the functional recovery in the short term if it exists.

Interventions

DEVICEHORUS

The trapezium-metacarpal arthroplasty consists of the installation of a bipolar prosthesis composed of a metacarpal implant and a trapezial implant articulated through a metacarpal "head".

Sponsors

Clinique Bizet
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
45 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Age \>45 years 2. Symptomatic trapezius-metacarpal osteoarthritis after failure of medical treatment ( night orthosis 3 months + failure of 2 infiltrations/year) 3. Patient who has given his/her consent to participate in the study after being informed by the surgeon, 4. Patient living in France and able to answer the survey alone. 5. Subject affiliated to a social security system or beneficiary of such a system 6. No participation in any other clinical study

Exclusion criteria

1. Minor patient 2. Trapezium height \< 8 mm 3. Major subject protected by law, under curatorship or guardianship 4. Known allergy to the materials of the medical device 5. Local infection 6. Local skin necrosis or unhealed wound 7. Pregnant or nursing women

Design outcomes

Primary

MeasureTime frameDescription
patient assessment of the wrist4 weeksQuick-Dash score (11 minimum value and 55 is maximum )

Secondary

MeasureTime frameDescription
patient assessment of the wrist pain4 weeksVisual Analogical Assessment score (0 no pain 10 severe pain)

Countries

France

Contacts

CONTACTBouchra BENKESSOU, PM
b.benkessou@hexagone-santé-paris.fr0764486016

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 11, 2026